ASKA Pharmaceutical Holdings Co.,Ltd. (TYO:4886)

-1.79% (1Y)

Market Cap	66.85B
Revenue (ttm)	64.14B
Net Income (ttm)	5.10B
Shares Out	28.36M
EPS (ttm)	179.95
PE Ratio	13.10
Forward PE	12.57
Dividend	55.00 (2.33%)
Ex-Dividend Date	Sep 29, 2025

Volume	36,800
Average Volume	39,865
Open	2,378.00
Previous Close	2,359.00
Day's Range	2,331.00 - 2,386.00
52-Week Range	1,825.00 - 2,544.00
Beta	0.45
RSI	43.77
Earnings Date	Aug 4, 2025

About TYO:4886

ASKA Pharmaceutical Holdings Co.,Ltd., through its subsidiaries, engages in the pharmaceutical, animal health, and hormone testing businesses in Japan. It operates through three segments: The Pharmaceutical Business, The Animal Health Business, and The Overseas Business. The company researches, develops, manufactures, and markets pharmaceutical products in the areas of endocrinology, obstetrics and gynecology, and urology; and researches, manufactures, sells, imports, and exports veterinary medicines, veterinary medical devices, feed and feed a...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1920
• Employees: 1,632
• Stock Exchange: Tokyo Stock Exchange
• Ticker Symbol: 4886

Financial Performance

In 2024, TYO:4886's revenue was 64.14 billion, an increase of 2.06% compared to the previous year's 62.84 billion. Earnings were 5.10 billion, a decrease of -32.39%.